SINGAPORE -- U.S. biotechnology unicorn 10x Genomics opened its Asia-Pacific headquarters and first overseas manufacturing facility in Singapore on Monday as the company aims to expand its presence in China and other regional markets.
The Nasdaq-listed company, which has a market capitalization of over $15 billion, designs and makes gene sequencing technology for scientific research, including products that have been used to support work in treating COVID-19. 10x sells both the machines and the software needed for analyzing biological systems.
